Literature DB >> 16163058

A xenograft nude mouse model for perineural invasion and recurrence in pancreatic cancer.

Guido Eibl1, Howard A Reber.   

Abstract

OBJECTIVE: Pancreatic cancer recurrence after initially "curative" resection is an unresolved clinical problem in the management of patients with this disease. Perineural invasion correlates with and might be partially responsible for tumor recurrence and poor survival. However, no adequate preclinical animal model is yet available to study this aspect of pancreatic cancer biology.
METHODS: We modified our orthotopic xenograft model of pancreatic cancer in nude mice to develop a model for pancreatic cancer perineural invasion and recurrence.
RESULTS: After initial orthotopic transplantation, complete surgical resection of MIA PaCa-2 (undifferentiated) and Capan-2 (well-differentiated) tumors at 4, 6, and 8 weeks was attempted. All animals that had undergone tumor resection survived the operation. Animals that had the MIA PaCa-2 tumor resected after 6 weeks developed recurrent pancreatic cancer with local invasion and distant metastasis. Histological evaluation revealed extensive invasion of retroperitoneal nerves by the cancer cells.
CONCLUSION: Complete resection of orthotopically transplanted pancreatic cancer in nude mice leads to local tumor recurrence. This model may eventually prove valuable for studying the mechanisms of pancreatic cancer perineural invasion and recurrence.

Entities:  

Mesh:

Year:  2005        PMID: 16163058     DOI: 10.1097/01.mpa.0000175176.40045.0f

Source DB:  PubMed          Journal:  Pancreas        ISSN: 0885-3177            Impact factor:   3.327


  24 in total

1.  The phosphatase PHLPP1 regulates Akt2, promotes pancreatic cancer cell death, and inhibits tumor formation.

Authors:  Claudia Nitsche; Mouad Edderkaoui; Ryan M Moore; Guido Eibl; Noriyuki Kasahara; Janet Treger; Paul J Grippo; Julia Mayerle; Markus M Lerch; Anna S Gukovskaya
Journal:  Gastroenterology       Date:  2011-10-29       Impact factor: 22.682

Review 2.  How Schwann cells facilitate cancer progression in nerves.

Authors:  Sylvie Deborde; Richard J Wong
Journal:  Cell Mol Life Sci       Date:  2017-06-19       Impact factor: 9.261

3.  An In Vivo Murine Sciatic Nerve Model of Perineural Invasion.

Authors:  Sylvie Deborde; Yasong Yu; Andrea Marcadis; Chun-Hao Chen; Ning Fan; Richard L Bakst; Richard J Wong
Journal:  J Vis Exp       Date:  2018-04-23       Impact factor: 1.355

4.  Surgery for recurrent pancreatic ductal adenocarcinoma.

Authors:  Jörg Kleeff; Carolin Reiser; Ulf Hinz; Jeannine Bachmann; Jürgen Debus; Dirk Jaeger; Helmut Friess; Markus W Büchler
Journal:  Ann Surg       Date:  2007-04       Impact factor: 12.969

Review 5.  Study human pancreatic cancer in mice: how close are they?

Authors:  Yuqing Zhang; Leon Chen; Jingxuan Yang; Jason B Fleming; Paul J Chiao; Craig D Logsdon; Min Li
Journal:  Biochim Biophys Acta       Date:  2012-11-09

6.  Imaging-guided curative surgical resection of pancreatic cancer in a xenograft mouse model.

Authors:  Xiaoling Ni; Jingxuan Yang; Min Li
Journal:  Cancer Lett       Date:  2012-05-19       Impact factor: 8.679

Review 7.  Road map for pain management in pancreatic cancer: A review.

Authors:  Marie José Lahoud; Hampig Raphael Kourie; Joelle Antoun; Lana El Osta; Marwan Ghosn
Journal:  World J Gastrointest Oncol       Date:  2016-08-15

8.  Isolation of viable cancer cells in antibody-functionalized microfluidic devices.

Authors:  Xiangjun Zheng; Linan Jiang; Joyce Schroeder; Alison Stopeck; Yitshak Zohar
Journal:  Biomicrofluidics       Date:  2014-04-30       Impact factor: 2.800

Review 9.  Interplay of tumor microenvironment cell types with parenchymal cells in pancreatic cancer development and therapeutic implications.

Authors:  Praveen Guturu; Vijay Shah; Raul Urrutia
Journal:  J Gastrointest Cancer       Date:  2009-06-10

Review 10.  Cancer proteomics by quantitative shotgun proteomics.

Authors:  Emily I Chen; John R Yates
Journal:  Mol Oncol       Date:  2007-09       Impact factor: 6.603

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.